KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.96

Healthcare Utilization, Costs, and Cost-Effectiveness of Patients Undergoing Laparoscopic and Open Hemihepatectomy: A Secondary Analysis of the ORANGE II PLUS Randomized Controlled, Phase 3, Superiority Trial.

Bram Olij, Gabriela Pilz da Cunha, Merel Kimman, Francesca Ratti, Mohammad Abu Hilal, Roberto I Troisi, Robert P Sutcliffe, Marc G Besselink, Somaiah Aroori, Krishna V Menon, Bjørn Edwin, Mathieu D'Hondt, Valerio Lucidi, Tom F Ulmer, Rafael Díaz-Nieto, Zahir Soonawalla, Steve White, Gregory Sergeant, Mariëlle M E Coolsen, Christoph Kuemmerli, Vincenzo Scuderi, Frederik Berrevoet, Aude Vanlander, Ravi Marudanayagam, Pieter J Tanis, Maxime J L Dewulf, Robert S Fichtinger, Zina B Eminton, Ulf P Neumann, Lloyd Brandts, Siân A Pugh, Åsmund A Fretland, John N Primrose, Ronald M van Dam, ORANGE II PLUS Collaborative

Ann Surg Oncol 33(4) 2882-2898

PMID41385067
PMCIDPMC12982277
DOI10.1245/s10434-025-18779-4
发表日期2025-12-12
入排依据:属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 3 张 PubMed Figure,均未识别为 KM 图:Fig. 1:CONSORT/入组流程图;Fig. 2:图注未提示 KM 曲线;Fig. 3:图注未提示 KM 曲线。
摘要

摘要

BACKGROUND: Laparoscopic hemihepatectomy (LH) has favorable short-term outcomes compared with open hemihepatectomy (OH), including shorter hospital stay. An in-depth healthcare utilization and cost-effectiveness analysis of the international multicenter ORANGE II PLUS randomized controlled trial comparing LH and OH was performed. PATIENTS AND METHODS: Patients were randomly assigned to LH or OH in 16 European centers from October 2013 to January 2019. Costs were determined as a product of unit costs using patient-level, clinician-reported resource utilization up to 90 days. Item-specific resource use per country was presented. The measure of effect was quality-adjusted life year (QALY). Cost and effect differences were compared between treatment arms using nonparametric bootstrapping, from a Dutch healthcare cost perspective. A cost-effectiveness analysis was performed to establish the incremental cost-effectiveness ratio (ICER), i.e., costs per QALY gained, for LH compared with OH 1 year postoperatively. RESULTS: Among 332 patients randomized to LH (n = 166) and OH (n = 166), intraoperative costs were higher for LH (LH 13,208 € versus OH 9437 €), while postoperative costs were lower for LH (LH 5774 € versus OH 7703 €). Longer operative time and greater instrument use contributed to higher intraoperative costs, while shorter hospital stays contributed to lower postoperative costs. Mean overall costs per patient were higher in LH (LH 18,982 € versus OH 17,141 €). The QALYs gained over 1 year postoperative were mean (standard deviation [SD]) 0.834 (0.218) for LH and mean 0.795 (0.237) for OH. The ICER was 36,677 € per additional QALY gained, and uncertainty analyses showed that LH had a 77% probability of being cost-effective compared with OH at a willingness-to-pay (WTP) threshold of 80,000 €. CONCLUSIONS: Although LH was more costly than OH, in a multicenter randomized trial, its clinical advantages translated into more QALYs gained over the first postoperative year and high probability of cost-effectiveness. These findings suggest that, where resources allow, LH may be preferred over OH for selected patients, offering both clinical benefits and acceptable economic value.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(3,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Fig. 1Fig. 1 Study CONSORT flow diagram
非 KM Figure
Fig. 2Fig. 2 Cost distribution over 90 days postoperatively. * Statistically significant bootstrapped mean difference. OH, open hemihepatectomy, LH laparoscopic hemihepatectomy
非 KM Figure
Fig. 3Fig. 3 a Cost-effectiveness analysis plane. Cost effectiveness plane for 5000 bootstrapped repetitions showing differences in total costs and QALYs between open and laparoscopic hemihepatectomy. A majority of the datapoints lie in the right upper quadrant, demonstrating laparoscopic hemihepatectomy is more effective but more costly. b Cost-effectiveness analysis probability curve. Cost-effectiveness acceptability curve showing the probability of laparoscopic hemihepatectomy being more cost-effective for various willingness-to-pay thresholds per QALY
非 KM Figure